Palladium-103

09/01/2018 - "Bilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation."
06/01/2011 - "Interventional case report describing a biopsy-proven multifocal iris melanoma treated with a palladium-103 plaque to include the entire anterior chamber within the targeted zone. "
11/15/1993 - "Palladium-103 (Pd-103) seeds in ophthalmic plaques were used to treat 15 patients with intraocular malignant melanoma. "
01/01/2018 - "A 12-Year Study of Slotted Palladium-103 Plaque Radiation Therapy for Choroidal Melanoma: Near, Touching, or Surrounding the Optic Nerve."
12/01/2002 - "Palladium-103 plaque radiotherapy for choroidal melanoma: an 11-year study."

11/01/1999 - "One hundred fifty-five prostate cancer patients underwent ultrasound-guided transperineal implantation of palladium-103 at the Hospital of the University of Pennsylvania between January 1994 and July 1998. "
01/01/2014 - "MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer."
09/01/1997 - "To describe the complexities of the medical management of patients undergoing treatment of prostate cancer; discuss the sequelae of treatment options, including surgery, external beam radiation, and brachytherapy; outline the evolution of interstitial prostatic brachytherapy and the current use of transperineal ultrasound-guided prostate implants using palladium-103 (103Pd), and discuss the side effects of the 103Pd prostate implant as well as the nursing management of patients who receive the implants. "
09/01/2016 - "Between May 1998 and December 2011, 2237 patients with early-stage prostate cancer from 11 Italian community and academic hospitals were treated with iodine-125 ((125)I) or palladium-103 LDR-BT as monotherapy and followed up for at least 2 years. "
09/01/2015 - "To determine the necessity and/or dose of supplemental external beam radiotherapy (EBRT) in conjunction with palladium-103 ((103)Pd) brachytherapy for high-risk prostate cancer patients. "

04/01/2019 - "The directional planar palladium-103 LDR device (CivaSheet TM ) may be used for intraoperative implantation at the interface between the tumor site and healthy tissue. "
12/01/2021 - "A novel Palladium-103 low-dose rate (LDR) brachytherapy device was developed to provide dose-escalation to the tumor bed after resection while shielding adjacent tissues. "
11/01/2018 - "Transcorneal intraocular tumor invasion was controlled using palladium-103 ophthalmic plaque radiation therapy applied through the natural and donor cornea. "
11/15/1993 - "Palladium-103 ophthalmic plaque brachytherapy resulted in slightly more irradiation of the tumor and less radiation to most normal ocular structures."
02/01/2014 - "Palladium-103 ophthalmic plaque radiation therapy can be used as an eye- and vision-preserving treatment for relatively large American Joint Committee on Cancer T3- or T4-sized choroidal melanomas."

07/15/2012 - "Lack of radiation maculopathy after palladium-103 plaque radiotherapy for iris melanoma."
12/01/2003 - "Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study."

06/01/2001 - "Patients treated for localized prostate carcinoma with either RP or interstitial palladium-103 (103Pd) HBTC or HBT were prospectively administered a voiding and sexual function questionnaire before any treatment was initiated and at posttreatment visits. "
12/15/2000 - "Materials and Methods: Forty-six consecutive patients who underwent Palladium-103 (Pd-103) seed placement for clinically localized prostate carcinoma were evaluated prospectively for any morbidity associated with the procedure. "
10/01/1997 - "Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate."
11/01/2000 - "Regarding Blasko et al. palladium-103 brachytherapy for prostate carcinoma. "
03/01/2000 - "Palladium-103 brachytherapy for prostate carcinoma."